Organization
Marienhospital Bottrop
1 abstract
Abstract
CAPTOR-BC: Comprehensive analysis of spatial, temporal and molecular biomarkers predicting response and resistance to first-line treatment with ribociclib + ET in HR+, HER2- advanced breast cancer.Org: Erlangen University Hospital, Department of Gynecology and Obstetrics, TU Dresden, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Beijing, China,